# Addition of Popliteal Plexus Block to Continuous Femoral Nerve Block for Total Knee Arthroplasty

> **NCT04048889** · NA · UNKNOWN · sponsor: **University Hospital, Geneva** · enrollment: 66 (estimated)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Ropivacaine 0.5% Injectable Solution
- **DRUG:** Ropivacaine 0.5% Injectable Solution
- **DRUG:** Ropivacaine 0.5% Injectable Solution

## Key facts

- **NCT ID:** NCT04048889
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-22
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2019-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04048889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04048889, "Addition of Popliteal Plexus Block to Continuous Femoral Nerve Block for Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT04048889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*